TLSI TriSalus Life Sciences, Inc.

$4.99 -3.01%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc. (TLSI) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $307 million. Shares last traded at $4.99, 37.0% below their 52-week high. Over the past year the stock is down 0.1%. Net profit margin is -62.6%, below the peer median of -9.3%. Revenue grew 53.4% year over year.

Market Cap

$307M

Shares Out

61.6M

EPS (TTM)

$-2.48

P/E Ratio

—

P/S Ratio

6.82

P/B Ratio

46.91

Dividend / Share

—

Dividend Yield

—

52-Week High

$7.92

52-Week Low

$2.21

Volume

3,421

Avg Vol (3m)

14,825.619

Performance

-0.20%

+7.78%

+51.44%

+4.18%

YTD

-17.93%

-0.10%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

49.92

SMA (50)

$4.73

SMA (200)

$4.84

Price vs SMA50

+5.54%

Price vs SMA200

+3.11%

ATR (14)

$0.30

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$45M

Net Income

$-28M

Gross Margin

85.8%

Operating Margin

-67.7%

Net Margin

-62.6%

Return on Equity

-430.7%

Return on Assets

-45.2%

Current Ratio

5.35

Debt / Equity

5.05

Revenue Growth (YoY)

+53.4%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.14	2026-08-06
Q1 2026	$0.03	2026-05-12
FY 2025	$-1.84	2026-03-05
Q3 2025	$-1.72	2025-11-13
Q2 2026	$-0.65	2026-08-06
Q1 2026	$-0.39	2026-05-12

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

TLSI vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

6.82 / 2.94 med

+132% premium

Net margin vs peers

-62.6% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.